This study described prescribing trends before and after implementing a provincial strategy aimed at improving osteoporosis and fracture prevention in Ontario long-term care (LTC) homes. Data were obtained from a pharmacy provider for 10 LTC homes in 2007 and 166 homes in 2012. We used weighted, multiple linear regression analyses to examine facility-level changes in vitamin D, calcium, and osteoporosis medication prescribing rates between 2007 and 2012. After five years, the estimated increase in vitamin D, calcium, and osteoporosis medication prescribing rates, respectively, was 38.2 per cent (95% confidence interval [CI]: 29.0, 47.3; p < .001), 4.0 per cent (95% CI: −3.9, 12.0; p = .318), and 0.2 per cent (95% CI: −3.3, 3.7; p = .91). Although the study could not assess causality, findings suggest that wide-scale knowledge translation activities successfully improved vitamin D prescribing rates, although ongoing efforts are needed to target homes with low uptake.
CIHR Author Manuscript
CIHR Author Manuscript
CIHR Author ManuscriptAn estimated 60 to 80 per cent of long-term care (LTC) residents have osteoporosis (Gloth & Simonson, 2008;Zimmerman et al., 1999) and in Canada, it is estimated that the fracture rate for LTC residents is approximately two to four times that of similarly aged communitydwelling residents (Crilly, Tanner, Kloseck, & Chesworth, 2010). Combined with agerelated losses in bone quantity and quality (Chen, Zhou, Fujita, Onozuka, & Kubo, 2013), the high prevalence of sarcopenia (Landi et al., 2012), frailty (Kanwar et al., 2013) and falls (Norris, Walton, Patterson, Feightner, & the Canadian Task Force on Preventive Health Care, 2003) in LTC residents may synergistically increase susceptibility for fractures (Ensrud et al., 2007;Ensrud et al., 2009;Gielen et al., 2012;Frisoli, Chaves, Ingham, & Fried, 2011). Furthermore, many LTC residents have sub-optimal vitamin D levels (Flicker et al., 2003;Ioannidis, Kennedy, Dykeman, Dudziak, & Papaioannou, 2012a), which is associated with lower bone mineral density (Bischoff-Ferrari, Dietrich, Orav, & Dawson-Hughes, 2004a;Bischoff-Ferrari et al., 2009;Hanley, Cranney, Jones, Whiting, & Leslie, 2010), decreased lower extremity function (Bischoff-Ferrari et al., 2004b;Dawson-Hughes, 2008), falls (Dawson-Hughes, 2008;Flicker et al., 2003), and fractures (Bischoff-Ferrari, Giovannucci, Willett, Dietrich, & Dawson-Hughes, 2006;Cauley et al., 2011;Holvik et al., 2013;Looker & Mussolino, 2008). In a Canadian LTC study , 54 per cent of all residents and 69 per cent of residents taking ≤ 400 IU/day had sub-optimal levels [25-hydroxyvitamin D (25(OH)D) < 75 nmol/L] for bone health (Hanley et al., 2010).In 2005, the Ontario Ministry of Health and LTC launched the Ontario Osteoporosis Strategy (Jaglal et al., 2010; Osteoporosis Action Plan Committee, 2003). This ongoing, population-based, strategic action plan is targeted at improving osteoporosis prevention and care across all residents in Ontario, with the overall goal of reducing morbidity, mortalit...